Greetings, and welcome to the MaxLinear fourth quarter 2024 earnings conference call. (Operator Instructions) As a reminder, this conference is being recorded. It is now my pleasure to introduce your ...

Investing.com -- Shares of MaxLinear (NASDAQ: MXL) plummeted 22% following the release of the company's fourth-quarter earnings and forward guidance, which fell short of investor expectations.

Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $22.7, along with a high estimate of $28.00 and a low estimate of $14.00. This upward trend ...

Northland Securities analyst Tim Savageaux reiterated a Buy rating on Maxlinear (MXL – Research Report) today and set a price target of $27.50.

David Williams, an analyst from Benchmark Co., reiterated the Buy rating on Maxlinear (MXL – Research Report). The associated price target ...

CEO Kishore Seendripu highlighted that Q4 2024 results surpassed guidance midpoint with $92.2 million in revenue and a non-GAAP gross margin of 59.1%. He emphasized ongoing strength in customer order ...

Wells Fargo has recently initiated Maxlinear Inc (MXL) stock to Equal Weight rating, as announced on November 22, 2024, according to Finviz. Earlier, on October 1, 2024, Susquehanna had reduced the ...

The Dow Jones and S&P 500 held onto gains. Nvidia sank below a moving average while medical test stocks breaks out.

Semiconductor stocks were mixed on Thursday, as investors digested results from some of the industry's most notable companies and awaited results from Intel (NASDAQ:INTC). STMicroelectronics (NYSE:STM ...